Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis

Author(s): Hiroshi Tsutsumi, Hirokazu Tamamura, Nobutaka Fujii

Journal Name: Letters in Drug Design & Discovery

Volume 4 , Issue 1 , 2007

Become EABM
Become Reviewer


The interaction between the chemokine, CXCL12 and its receptor, CXCR4 is known to be involved in several intractable disease processes, including HIV infection, cancer cell metastasis, leukemia cell progression and rheumatoid arthritis. It is conjectured that this interaction may be an important therapeutic target in all of these diseases, and various CXCR4 antagonists have been proposed as potential drugs. This article describes the development in our laboratory of a number of specific CXCR4 antagonists.

Keywords: Cancer metastasis, Chemokine receptor, HIV infection, Leukemia cell progression, Low molecular weight CXCR4 antagonist, Rheumatoid arthritis

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [20 - 26]
Pages: 7
DOI: 10.2174/157018007778992900

Article Metrics

PDF: 16